Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cardiome Receives Brinavess Approval in Turkey | Contract Pharma

What are you searching for?

Sign in
Trials & Filings

Cardiome Receives Brinavess Approval in Turkey

AF treatment approved by Ministry of Health

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Cardiome Pharma Corp.‘s Brinavess has been approved in Turkey by the Turkish Ministry of Health for the rapid conversion of recent onset atrial fibrillation (AF) to sinus rhythm in adults.

“We are pleased to receive approval for Brinavess in Turkey,” said Karim Lalji, Cardiome’s chief commercial officer. “This decision confirms Cardiome’s commitment to pursue Brinavess approvals beyond the EU region. We will seek a local distribution partnership in this key market in order to optimize the commercialization and launch and make Brinavess available for the benefit of patients suffering from AF.”

According to the European Federation of Pharmaceutical Industry and Associations Pharmaceutical Industry Report, total sales for the pharmaceutical market in Turkey totaled $9.7 billion in 2011.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics